Patients For Affordable Drugs Announces New Communications Director
As The Fight To Lower Drug Prices Ramps Up, Audrey Baker Will Lead P4AD’s Communications Efforts
As The Fight To Lower Drug Prices Ramps Up, Audrey Baker Will Lead P4AD’s Communications Efforts
New Report Debunks Pharma's Claim That Any Restraint On Its Unilateral Pricing Power Will Destroy Innovation And Access To New Medicines.
Veteran Advocacy Leader Sheila McLean Takes The Helm At Critical Moment For Drug Pricing Reform.
Nearly 150 More Price Increases In Just The Last Two Weeks Bring Total To 783
Median price hike of 4.99 percent is more than four times the rate of inflation.
Big Pharma Should Thank Taxpayers For Low-Risk, High-Profit COVID-19 Vaccine Development.
Seventy companies raised prices on hundreds of drugs by an average of almost three times the rate of inflation.
Vital Drugs Important To COVID-Related Outcomes See Big Bumps.
Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.